Commentary

Implant therapy has improved the treatment outcomes for restoring missing teeth in the past decades. The key factors for long-term implant survival are bone quantity and quality. Furthermore, the rehabilitation with implant-supported prostheses of the edentulous in the posterior maxillary regions often presents a challenge due to reduced residual alveolar bone and increased pneumatisation of the maxillary sinus. In many of these patients, sinus augmentation procedure has been used to overcome this problem by using bone grafting. Over the last ten years, maxillary sinus augmentation procedure has become a routine indication to increase the available bone height for implant placement and subsequent prosthetic reconstruction.

Evidence-based reviews reported and compared implant survival rates in augmented sinuses utilising various surgical techniques, implant surfaces and grafting materials.1,2 These reviews concluded that maxillary sinus augmentation can be a predictable grafting procedure for placing dental implants in the severely atrophic posterior maxilla. However, the possibility of surgical complications exists and should be considered.

Some alternative approaches have been utilised to overcome the problem of inadequate bone quantity including, but not limited to, the use of a short implant (4 to 8 mm long). The main advantage of a short implant is that it avoids the need for entering the sinus cavity and use of bone graft, although a minimum of 5-6 mm of residual bone height is still required. However, a critical clinical question is whether implants placed in a grafted sinus present a higher risk of failure than the use of short implants in posterior atrophic maxillae. This is why this is a clinically relevant topic so as to clarify the specific indications for each treatment.

In 2014, an update3 of a Cochrane review first published in 20104 from the Cochrane Oral Health Group compared the predictability of bone augmentation to no augmentation when undertaking sinus lift procedures. In addition to that, they compared different maxillary sinus augmentation techniques for implant rehabilitation. It was conducted with an appropriate methodology, with no restrictions on language or date of publication, databases were search, a thorough critical appraisal was performed. A grade of the evidence for each outcome was presented using the GRADE profiler, summarising the findings, quality of evidence and strength of the recommendations. The authors' grading for the overall risk of selection bias was moderate. It concluded that there is insufficient evidence to determine whether sinus lift procedures in bone with residual height are more or less successful than placing short implants in reducing prosthesis or implant failures. Only a few studies were included in the meta-analysis for prosthetic and implant failures. The combined statistics of similar studies (low heterogeneity) shows no statistically significant results. There is also insufficient evidence to conclude that different sinus lift procedures lead to fewer prosthesis or implant failures than the other. However, there was some statistically significant difference observed among studies of increased complications at sites involving sinus lift procedures. The overall result is statistically significant. However, a large confidence interval is noted and some statistical heterogeneity was observed in the meta-analysis. The clinical applicability of the results is inconclusive.

Given the lack of evidence, and small number included in the meta-analysis, larger, long-term, well designed controlled clinical trials are needed.

Therefore, clinicians may treat suitable patients with severely atrophic posterior maxilla when a methodical preoperative evaluation is performed, including careful case planning, surgical technique and biomaterial selection. Finally, the validity of new procedures specifically to treat these regions must be fully evaluated.